Convenience And Preferability Among Patients with Sickle Cell Anemia on Iron Cheloter
Academic International Journal of Medical Update · 15.11.2025 · 20-27
DOI: 10.59675/u323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic International Journal of Medical Update, online erschienen am 15.11.2025. Verfasst von Kamal Rawdhan Mohaisen und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
SCD is a chronic hemolytic disease that is significant and has a broad spectrum of complications. The value of blood transfusion in SCD is becoming increasingly evident. If left untreated, the resulting iron excess can be life-threatening. Parenteral infusions are necessary for chelation therapy with deferoxamine, which can have a detrimental effect on drug adherence and quality of life.
Methods
Deferoxamine (20-50 mg\kg\day) or oral deferasirox (20-40 mg\kg\day) was administered to 97 patients in a 2:1 randomized fashion. A total of 60 patients have received this medication previously.
Results
At the end of each interval of questioning, a significantly greater number of people who passed the time up and took medication were either (satisfied\ delighted) with deferasirox or identified the treatment as {preferable\very preferable} compared to deferoxamine (p = 0,001). Deferasirox resulted in fewer hours lost from daily activities than deferoxamine in those patients. At the conclusion of the investigation, most patients expressed their willingness to continue their oral therapy (84 vs 11%).
Conclusions
Therefore, patients with SCD are more satisfied with deferasirox, as it exerts a lesser impact on daily activities than deferoxamine. Enhanced quality of life is associated with a high level of satisfaction. The improved treatment outcome is associated with high oral chelation adherence.
Zitieren
APA
Mohaisen, K. R., Shabbani, A. M. A., & Ghazi, H. M. (2025). Convenience And Preferability Among Patients with Sickle Cell Anemia on Iron Cheloter. Academic International Journal of Medical Update, 20-27. https://doi.org/10.59675/u323
Vancouver
Mohaisen KR, Shabbani AMA, Ghazi HM. Convenience And Preferability Among Patients with Sickle Cell Anemia on Iron Cheloter. Academic International Journal of Medical Update. 2025:20-27. doi:10.59675/u323
BibTeX
@article{Mohaisen2025,
author = {Mohaisen, Kamal Rawdhan and Shabbani, Alaa MutarJebur Al and Ghazi, Hussein Mohammed},
title = {Convenience And Preferability Among Patients with Sickle Cell Anemia on Iron Cheloter},
journal = {Academic International Journal of Medical Update},
year = {2025},
pages = {20--27},
doi = {10.59675/u323}
}
EUVIMED